4/A: AMN Healthcare CFO Amends Ownership Filing

AMN Healthcare's CFO, Brian M. Scott, filed an amended Form 4 to correct an overstatement of beneficially owned derivative securities.

Summary

• Brian M. Scott, CFO/COO of AMN Healthcare Services Inc., filed an amended Form 4 (Form 4/A) on January 29, 2026.
• The amendment corrects an administrative error in the original Form 4 filed on January 16, 2026, which overstated beneficially owned derivative securities by 40,920 shares.
• The corrected amount of beneficially owned derivative securities following the reported transaction is 40,920, not 81,840 as previously reported.
• On January 15, 2026, 8,843 shares of common stock were acquired by Mr. Scott upon the vesting of Restricted Stock Units (RSUs) granted under the AMN Healthcare 2017 Equity Plan.
• Concurrently, 3,592 shares of common stock were disposed of at a price of $19.55 per share to cover tax obligations related to the RSU vesting.
• Additionally, 40,920 new Restricted Stock Units were granted to Mr. Scott on January 15, 2026, under the AMN Healthcare 2025 Equity Plan.
• These newly granted RSUs represent a contingent right to receive one share of AMN Common Stock each and will vest in three tranches on the first, second, and third anniversaries of the grant date.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the administrative error requiring an amendment, though the underlying RSU grants and vesting are routine executive compensation events.

Positives

• The vesting of 8,843 Restricted Stock Units indicates continued performance and retention of the CFO.
• The grant of 40,920 new Restricted Stock Units aligns the CFO's long-term incentives with shareholder value.

Negatives

• An administrative error in the initial Form 4 led to an overstatement of beneficially owned derivative securities by 40,920 shares, requiring an amendment.
• The disposal of 3,592 shares for tax purposes reduces the CFO's direct common stock holdings.

Future Outlook

The newly granted 40,920 Restricted Stock Units will vest in three tranches on the first, second, and third anniversaries of the January 15, 2026 grant date, contingent on the grantee's provision of three periods of credited service.

Industry Context

StockSavvy.ai notes that executive equity grants and vesting events are standard practice in the healthcare staffing industry, aligning executive incentives with long-term company performance. The administrative error, while minor, highlights the importance of accurate and timely SEC disclosures.

Comparison to Industry Standards

• This filing details standard executive compensation practices, including RSU grants and vesting, which are common across publicly traded companies.
• The tax withholding for RSU vesting is also a routine event.
• No specific comparable companies or projects are mentioned in the filing to allow for a detailed comparison of results.

Stakeholder Impact

• Shareholders: The correction of the administrative error ensures accurate reporting of executive beneficial ownership, which is crucial for transparency. The RSU grants align executive incentives with shareholder interests.

Next Steps

• Future vesting of 40,920 Restricted Stock Units in three tranches on the first, second, and third anniversaries of January 15, 2026.

Key Dates

Recommendation

This Form 4/A primarily corrects an administrative error in a previous filing regarding executive beneficial ownership and details routine RSU vesting and new grants. It does not contain information significant enough to warrant a change in investment recommendation for AMN Healthcare Services Inc. The core business operations and financial performance are not addressed in this filing.

Keywords

AMN Healthcare, AMN, Form 4/A, SEC Filing, Beneficial Ownership, Restricted Stock Units, RSU, CFO, Executive Compensation, Insider Trading, Equity Plan, Stock Grant, Tax Withholding